Search | WHO COVID-19 Research Database

A Case of Multisystem Inflammatory Syndrome in a 12-Year-old Male After COVID-19 mRNA Vaccine.

Yalçinkaya, Rumeysa; Öz, Fatma Nur; Polat, Meltem; Uçan, Berna; Teke, Türkan Aydin; Kaman, Ayse; Özdem, Suna; Savas Sen, Zeynep; Cinni, Rüveyda Gümüser; Tanir, Gönül.

Pediatr Infect Dis J ; 41(3): e87-e89, 2022 03 01.

Article in English | MEDLINE | ID: covidwho-1608728

ABSTRACT

The pathophysiology of multisystem inflammatory syndrome (MIS) in children (MIS-C) is unknown. It occurs several weeks after COVID-19 infection or exposure; however, MIS is rarely reported after COVID-19 vaccination, and cases are mostly in adults. Herein, we present a 12-year-old male who had no prior COVID-19 infection or exposure and developed MIS-C after his first dose of COVID-19 mRNA vaccine.

Subject(s)

COVID-19 Vaccines/adverse effects , COVID-19/complications , Systemic Inflammatory Response Syndrome/etiology , Vaccines, Synthetic/adverse effects , mRNA Vaccines/adverse effects , COVID-19/diagnosis , COVID-19/etiology , COVID-19/prevention & control , Child , Diagnosis, Differential , Drug Therapy, Combination , Glucocorticoids/therapeutic use , Humans , Immunoglobulins, Intravenous/therapeutic use , Male , Methylprednisolone/therapeutic use , SARS-CoV-2 , Systemic Inflammatory Response Syndrome/diagnosis , Systemic Inflammatory Response Syndrome/drug therapy , COVID-19 Drug Treatment

ABSTRACT

Subject(s)

SEND TO:

SELECTION OF CITATIONS

SEARCH DETAIL